These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34305924)

  • 1. Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders.
    Steele H; Sachen K; McKnight AJ; Soloff R; Herro R
    Front Immunol; 2021; 12():692127. PubMed ID: 34305924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 5. TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling.
    Herro R; Miki H; Sethi GS; Mills D; Mehta AK; Nguyen XX; Feghali-Bostwick C; Miller M; Broide DH; Soloff R; Croft M
    J Immunol; 2020 Nov; 205(9):2414-2422. PubMed ID: 32958689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma.
    Niese ML; Pajulas AL; Rostron CR; Cheung CCL; Krishnan MS; Zhang J; Cannon AM; Kaplan MH
    Mucosal Immunol; 2024 Aug; 17(4):537-553. PubMed ID: 38493956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
    Shih DQ; Zheng L; Zhang X; Zhang H; Kanazawa Y; Ichikawa R; Wallace KL; Chen J; Pothoulakis C; Koon HW; Targan SR
    Mucosal Immunol; 2014 Nov; 7(6):1492-503. PubMed ID: 24850426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.
    Liu X; Zhang J; Zhang D; Pan Y; Zeng R; Xu C; Shi S; Xu J; Qi Q; Dong X; Wang J; Liu T; Dong L
    Respir Res; 2024 Jul; 25(1):271. PubMed ID: 38987753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TL1A-DR3 Axis in Asthma: Membrane-Bound and Secreted TL1A Co-Determined the Development of Airway Remodeling.
    Zhang J; Zhang D; Pan Y; Liu X; Xu J; Qiao X; Cui W; Dong L
    Allergy Asthma Immunol Res; 2022 Mar; 14(2):233-253. PubMed ID: 35255540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
    Holmkvist P; Roepstorff K; Uronen-Hansson H; Sandén C; Gudjonsson S; Patschan O; Grip O; Marsal J; Schmidtchen A; Hornum L; Erjefält JS; Håkansson K; Agace WW
    Mucosal Immunol; 2015 May; 8(3):545-58. PubMed ID: 25269704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial-Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.
    Zhang D; Yang H; Dong XL; Zhang JT; Liu XF; Pan Y; Zhang J; Xu JW; Wang ZH; Cui WJ; Dong L
    Front Immunol; 2022; 13():854995. PubMed ID: 35359966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.
    Taraban VY; Slebioda TJ; Willoughby JE; Buchan SL; James S; Sheth B; Smyth NR; Thomas GJ; Wang EC; Al-Shamkhani A
    Mucosal Immunol; 2011 Mar; 4(2):186-96. PubMed ID: 20962771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
    Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
    Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TL1A monoclonal antibody modulates the dysregulation of Th1/Th17 cells and attenuates granuloma formation in sarcoidosis by inhibiting the PI3K/AKT signaling pathway.
    Ma C; Huang J; Zheng Y; Na Y; Wei J; Shan J; Meng K; Zhang X; Zhang S; Wen Y; Ding J
    Int Immunopharmacol; 2024 Aug; 137():112360. PubMed ID: 38852524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
    Mavers M; Simonetta F; Nishikii H; Ribado JV; Maas-Bauer K; Alvarez M; Hirai T; Turkoz M; Baker J; Negrin RS
    Front Immunol; 2019; 10():1624. PubMed ID: 31379829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.